The core risk is commercialization quality, not scientific ambition.
QCi now owns more real
photonics and packaging surface area than many microcap quantum peers, but the next five years still hinge on converting
backlog and pilot-style wins into accepted shipments, better utilization, and repeat demand. If that proof arrives, the model can scale fast from a small base; if it does not, valuation and
unit economics are both vulnerable.